iiinova — where your digital self keeps evolving

Lauren Floyd

@doclfloyd.bsky.social

46 followers 61 following 0 posts

Renal Reg in North West, UK / Research interests in Vasculitis and GN / ERA YNP Board member

Posts Replies Media

Reposted by Lauren Floyd

Nephrology Journal Club @nephjc.bsky.social · 01/01/2025

As we welcome 2025 and say goodbye to 2024- another amazing year in nephrology- you the #NephJC community voted for them... Here are the top NEPHROLOGY stories of 2024! Join us 9pm EST on 1/7/25 as we chat about what were practice and life changing events of the past year. #NephSky #MedSky

22821

Reposted by Lauren Floyd

haysamrady @sodatroubles.bsky.social · 09/01/2025

Belimumab versus telitacicept in sequential treatment after rituximab for refractory #lupus nephritis: a real-world multicentre study #nephsky lupus.bmj.com/content/12/1...

lupus.bmj.com

Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been approved as add-on therapies for SLE in China. The aim of this study is to compar...

041

Reposted by Lauren Floyd

KDIGO @kdigo.org · 09/01/2025

🌟 KDIGO is now on Bluesky! 🌟 We’re excited to connect with the nephrology community on this platform and share the latest from KDIGO, including guidelines, reports, and educational resources. We’d like to introduce KDIGO, what we do, and how to connect with us. 🧵👇 🔗 kdigo.org #NephSky

14219